KCNN4 contributes the pro-inflammatory activation of microglia [50], with blocking of this channel shown to improve CNS outcomes following traumatic brain injury [51, 52] and has been proposed as a potential therapeutic for microglia neurotoxicity in Alzheimer’s disease [53]. This evidence concerns the gene KCNN4 and early-onset autosomal dominant Alzheimer disease.